The Brand Name MENOGIA Has Generic Salt :: Tranexamic 

MENOGIA  Is From Company Gufic Bio. Priced :: Rs. 83

MENOGIA have Tranexamic is comes under Sub class Hemostatics,Hemorrheologic of  Main Class Hematological System

Main Medicine Class:: Hematological System  Sub Medicine Class :: Hemostatics,Hemorrheologic 

 Salt Name :  OR Generic Name Form Price : MRP /Probable Packing
Tranexamic  TAB  Rs. 83  6
Brand Name Company / Manufacturers Strength Unit Price / 6
 MENOGIA  Gufic Bio.  500MG  6 Rs. 83

Company  Brand Name  Salt Combination Main Medical Class Sub Medical Class
 From Gufic Bio. :: MENOGIA  Tranexamic  Hematological System Hemostatics,Hemorrheologic

Indications for Drugs ::

Haemorrhage, Hereditary angioedema

Drug Dose ::

Adult: PO Short-term management of haemorrhage 1-1.5 g 2-3 times/day. Long-term management of hereditary angioedema 1-1.5 g 2-3 times/day. Child: 25 mg/kg bid or tid. IV Short-term management of haemorrhage 0.5-1 g 3 times/day. Child: 10 mg/kg bid or tid.

Contraindication ::

Severe renal failure, active intravascular clotting, thromboembolic disease, colour vision disorders, subarachnoid bleeding.

Drug Precautions ::

Mild to moderate renal impairment, irregular menstrual bleeding, previous history of thromboembolic disease, haematuria. Monitor closely in disseminated intravascular coagulation. Monitor LFT and eye examination regularly during long-term use. Discontinue if disturbance in colour vision occurs. Avoid IV inj rate >1 ml/minute due to risk of hypotension. Pregnancy, lactation.

Drug Side Effects ::

Diarrhoea, nausea, vomiting, disturbances in colour vision, giddiness, hypotension (after rapid IV inj), thromboembolic events.

Pregnancy category ::
Pregnancy category


Drug Mode of Action ::  

Tranexamic acid is an antifibrinolytic agent that competitively inhibits breakdown of fibrin clots. It blocks binding of plasminogen and plasmin to fibrin, thereby preventing haemostatic plug dissolution.

Drug Interactions ::

Potentially Fatal: Increased risk of thrombus formation with estrogens, Factor IX complex concentrates or anti-inhibitor coagulant concentrates. Increased risk of fatal thrombotic complications with tretinoin in acute promyelocytic leukaemia.


Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

We would like to keep you updated with special notifications.